364 related articles for article (PubMed ID: 28806769)
41. Risk of Post-TKA Acute Myocardial Infarction in Patients With a History of Myocardial Infarction or Coronary Stent.
Kumar A; Tsai WC; Tan TS; Chiu LT; Kung PT; Lo CK; Ku MC
Clin Orthop Relat Res; 2016 Feb; 474(2):479-86. PubMed ID: 26566978
[TBL] [Abstract][Full Text] [Related]
42. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).
Dasari TW; Cohen DJ; Kleiman NS; Keyes MJ; Yen CH; Hanna EB; Saucedo JF
Am J Cardiol; 2014 Feb; 113(4):621-5. PubMed ID: 24342762
[TBL] [Abstract][Full Text] [Related]
43. Time-dependent prognostic effect of high sensitivity C-reactive protein with statin therapy in acute myocardial infarction.
Kang DO; Park Y; Seo JH; Jeong MH; Chae SC; Ahn TH; Jang WY; Kim W; Park EJ; Choi BG; Na JO; Choi CU; Kim EJ; Rha SW; Park CG; Seo HS;
J Cardiol; 2019 Jul; 74(1):74-83. PubMed ID: 30745001
[TBL] [Abstract][Full Text] [Related]
44. Early statin initiation and outcomes in patients with acute coronary syndromes.
Newby LK; Kristinsson A; Bhapkar MV; Aylward PE; Dimas AP; Klein WW; McGuire DK; Moliterno DJ; Verheugt FW; Weaver WD; Califf RM;
JAMA; 2002 Jun; 287(23):3087-95. PubMed ID: 12069671
[TBL] [Abstract][Full Text] [Related]
45. Statin has more protective effects in AMI patients with higher plasma BNP or NT-proBNP level, but not with lower left ventricular ejection fraction.
Cho J; Park IB; Lee K; Ahn TH; Park WB; Kim JH; Ahn Y; Jeong MH; Lee DH;
J Cardiol; 2018 Apr; 71(4):375-381. PubMed ID: 29158023
[TBL] [Abstract][Full Text] [Related]
46. Coronary Artery Ectasia Predicts Future Cardiac Events in Patients With Acute Myocardial Infarction.
Doi T; Kataoka Y; Noguchi T; Shibata T; Nakashima T; Kawakami S; Nakao K; Fujino M; Nagai T; Kanaya T; Tahara Y; Asaumi Y; Tsuda E; Nakai M; Nishimura K; Anzai T; Kusano K; Shimokawa H; Goto Y; Yasuda S
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2350-2355. PubMed ID: 29051141
[TBL] [Abstract][Full Text] [Related]
47. Preprocedural statin use in patients undergoing percutaneous coronary intervention.
Kenaan M; Seth M; Aronow HD; Naoum J; Wunderly D; Mitchiner J; Moscucci M; Gurm HS;
Am Heart J; 2014 Jul; 168(1):110-6.e3. PubMed ID: 24952867
[TBL] [Abstract][Full Text] [Related]
48. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
[TBL] [Abstract][Full Text] [Related]
49. Long-term Survival Benefit of Statin in Patients with Coronary Chronic Total Occlusion without Revascularization.
Kim BS; Yang JH; Jang WJ; Song YB; Hahn JY; Choi JH; Choi KH; Kim SH; Chun WJ; Gwon HC; Choi SH
J Korean Med Sci; 2018 Apr; 33(18):e134. PubMed ID: 29713254
[TBL] [Abstract][Full Text] [Related]
50. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.
Lee SW; Kim SH; Kim SO; Han S; Kim YH; Park DW; Kang SJ; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2012 Aug; 80(2):206-12. PubMed ID: 22234884
[TBL] [Abstract][Full Text] [Related]
51. Statin therapy in the reduction of cardiovascular events in patients undergoing intermediate-risk noncardiac, nonvascular surgery.
Raju MG; Pachika A; Punnam SR; Gardiner JC; Shishehbor MH; Kapadia SR; Abela GS
Clin Cardiol; 2013 Aug; 36(8):456-61. PubMed ID: 23670940
[TBL] [Abstract][Full Text] [Related]
52. Effectiveness of preprocedural statin therapy on clinical outcomes for patients with stable coronary artery disease after percutaneous coronary interventions.
Ko DT; Wijeysundera HC; Yun L; Austin PC; Cantor WJ; Tu JV
Circ Cardiovasc Qual Outcomes; 2011 Jul; 4(4):459-66. PubMed ID: 21712520
[TBL] [Abstract][Full Text] [Related]
53. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
[TBL] [Abstract][Full Text] [Related]
54. Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction.
Lee JH; Bae MH; Yang DH; Park HS; Cho Y; Lee WK; Jeong MH; Kim YJ; Cho MC; Kim CJ; Chae SC;
Korean J Intern Med; 2016 Mar; 31(2):267-76. PubMed ID: 26701233
[TBL] [Abstract][Full Text] [Related]
55. Moderate-intensity versus high-intensity statin therapy in Korean patients with angina undergoing percutaneous coronary intervention with drug-eluting stents: A propensity-score matching analysis.
Park MW; Park GM; Han S; Yang Y; Kim YG; Roh JH; Park HW; Suh J; Cho YR; Won KB; Ann SH; Kim SJ; Kim DW; Her SH; Lee SG
PLoS One; 2018; 13(12):e0207889. PubMed ID: 30532220
[TBL] [Abstract][Full Text] [Related]
56. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Chieffo A; Meliga E; Latib A; Park SJ; Onuma Y; Capranzano P; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Kim YH; Buszman PE; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capodanno D; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2012 Jul; 5(7):718-27. PubMed ID: 22814776
[TBL] [Abstract][Full Text] [Related]
57. Prognostic impact of significant non-infarct-related left main coronary artery disease in patients with acute myocardial infarction who receive a culprit-lesion percutaneous coronary intervention.
Seo SM; Kim TH; Kim CJ; Hwang BH; Kang MK; Koh YS; Min J; Chang K; Kim PJ; Park HJ; Chung WS; Jeong MH; Kim YJ; Park SJ; Seung KB;
Coron Artery Dis; 2012 Aug; 23(5):307-14. PubMed ID: 22527385
[TBL] [Abstract][Full Text] [Related]
58. Effect of statins and white blood cell count on mortality in patients with ischemic left ventricular dysfunction undergoing percutaneous coronary intervention.
Lipinski MJ; Martin RE; Cowley MJ; Goudreau E; Malloy WN; Johnson RE; Vetrovec GW
Clin Cardiol; 2006 Jan; 29(1):36-41. PubMed ID: 16477776
[TBL] [Abstract][Full Text] [Related]
59. Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention: Meds Matter: Impact of Adherence to Medical Therapy on Comparative Outcomes.
Kurlansky P; Herbert M; Prince S; Mack M
Circulation; 2016 Oct; 134(17):1238-1246. PubMed ID: 27777293
[TBL] [Abstract][Full Text] [Related]
60. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
